Posts Archive

NCT06158841: Phase 3: Intravenous (IV) ABBV-383 Monotherapy Versus Standard Therapies RRMM Study Assessing Activity of Intravenous (IV)...

Myeloma UK Publication, intended for UK Audience Myeloma – An Introduction - Myeloma Essentials https://www.myeloma.org.uk/...

NCCN GUIDELINES FOR PATIENTS: MULTIPLE MYELOMA 2023 Click here to see patient's guideline book by NCCN. Presented with support from: NCCN...

www.uptodate.com - What is Multiple Myeloma? Patient education: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)...

How to Navigate through MCT Website and find high yield topics. You can also search any topic in search bar to find related posts....

Patient Education: Daratumumab & Daratumumab and Hyaluronidase-fihj DARATUMUMAB (DARZALEX) NIH National cancer institute - cancer.gov...

Patient Education: Revlimid (lenalidomide) - Immunomodulatory Agents - IMIDS LENALIDOMIDE (REVLIMID) NIH National cancer institute...

Patient Education: Bortezomib (Velcade) - Proteasome Inhibitors BORTEZOMIB (VELCADE) NIH National cancer institute -cancer.gov site info...

Patient Education: Carfilzomib (Kyprolis) - Proteasome Inhibitor Carfilzomib NIH National cancer institute - cancer.gov site info This...

MajesTEC-9 - Teclistamab alone Vs PVd Vs Kd - RRMM NCT05572515: Phase 3: A Study Comparing Teclistamab Monotherapy Versus Pomalidomide,...

Patient Education: Ciltacabtagene Autoleucel https://www.carvykti.com Ciltacabtagene Autoleucel ( Carvykti) FDA approves ciltacabtagene...

Patient Education: Idecabtagene Vicleucel ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically...

Patient Education: Isatuximab-irfc - Sarclisa - Monoclonal Antibody - Immunotherapy ISATUXIMAB-IRFC (SARCLISA) NIH National cancer...

Patient Education: Pomalidomide (Pomalyst) Immunomodulatory Agents - IMIDS POMALIDOMIDE (POMALYST) NIH National cancer institute -...

Patient Education: Elotuzumab (Empliciti) - Anti-SLAMF7 Monoclonal Antibody - Immunotherapy ELOTUZUMAB (EMPLICITI) NIH National cancer...

Patient Education: Thalidomide (Thalomid) Immunomodulatory Agents - IMIDS THALIDOMIDE NIH National cancer institute - cancer.gov site...

Why is it important to become your own best advocate? Why is it important to become your own best myeloma advocate? HealthTree University...

What is a Myeloma Specialist, Why do I Need one, and How do I Find One? HealthTree University Myeloma Dec 13, 2019 Learn more: HealthTree...

Patient Education: Ixazomib (Ninlaro) - Proteasome Inhibitor IXAZOMIB (NINLARO) NIH National cancer institute - cancer.gov site info This...

Patient Education: Selinexor (Xpovio) - XPO1 inhibitor Selinexor (Xpovio) NIH National cancer institute - cancer.gov site info This page...

MagnetisMM-8 NCT05228470: Phase 2: MagnetisMM-8: Study Of Elranatamab (PF-06863135) Monotherapy in Chinese Participants With Refractory...

Patient Education: Dexamethasone and other steroids DEXAMETHASONE (DECADRON) NIH National cancer institute -cancer.gov site info on...

(GEM21menos65) (Isatuximab-VRD + ASCT) - (VRD extended + ASCT plus ERI) - (Isatuximab-VID + ASCT). ERI=Early Rescue Intervention...